Da Xu
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 33
- Colorectal Cancer Treatments and Studies 12
- Cancer Immunotherapy and Biomarkers 8
- Pancreatic and Hepatic Oncology Research 8
-
- RNA modifications and cancer 6
- Co-authors
- Ying Zhu (13 shared papers)Qiongzhu Dong (9 shared papers)Ze Zhang (8 shared papers)Baocai Xing (18 shared papers)Yan Zheng (7 shared papers)Lun–Xiu Qin (9 shared papers)Kun Wang (11 shared papers)Lu Lu (3 shared papers)
- Journals
- Cancer Cell International (4 papers)European Journal of Surgical Oncology (3 papers)Annals of Surgical Oncology (3 papers)Cell Reports Medicine (2 papers)Gut (2 papers)
- Partner nations
- ChinaEthiopiaUnited States
In The Last Decade
Da Xu
68 papers receiving 2.1k citations
Da Xu's Hit Papers
Peers
Comparison fields: 5 of 110
- Cancer Research 592
- Hepatology 297
- Transplantation 97
- Oncology 609
- Immunology 379
Countries citing papers authored by Da Xu
This map shows the geographic impact of Da Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Da Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Da Xu more than expected).
Fields of papers citing papers by Da Xu
This network shows the impact of papers produced by Da Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Da Xu. The network helps show where Da Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Da Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade Hit paper breakdown → | 2019 | 333 |
| 2 | 2020 | 329 | |
| 3 | 2019 | 118 | |
| 4 | 2020 | 90 | |
| 5 | 2022 | 68 | |
| 6 | 2018 | 61 | |
| 7 | 2020 | 57 | |
| 8 | 2018 | 49 | |
| 9 | 2016 | 48 | |
| 10 | 2018 | 47 | |
| 11 | 2020 | 46 | |
| 12 | 2019 | 44 | |
| 13 | 2020 | 43 | |
| 14 | 2024 | 42 | |
| 15 | 2023 | 40 | |
| 16 | 2018 | 38 | |
| 17 | 2017 | 35 | |
| 18 | 1993 | 32 | |
| 19 | 2023 | 32 | |
| 20 | 2017 | 31 |
About Da Xu
Da Xu is a scholar working on Oncology, Molecular Biology, Hepatology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 71 papers that have together received 2.1k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (22 papers), Colorectal Cancer Treatments and Studies (12 papers), Ferroptosis and cancer prognosis (10 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers), Cancer Immunotherapy and Biomarkers (8 papers), Pancreatic and Hepatic Oncology Research (8 papers), Cancer, Hypoxia, and Metabolism (7 papers) and RNA modifications and cancer (6 papers). The work is most often cited by research in Cancer Research (592 citations), Hepatology (297 citations), Transplantation (97 citations), Oncology (609 citations) and Immunology (379 citations). Da Xu has collaborated with scholars based in China, Ethiopia and United States. Frequent co-authors include Ying Zhu, Qiongzhu Dong, Ze Zhang, Baocai Xing, Yan Zheng, Lun–Xiu Qin, Kun Wang, Lu Lu, Hu‐Liang Jia and Peijun Zhou. Their work appears in journals such as Cancer Cell International, European Journal of Surgical Oncology, Annals of Surgical Oncology, Cell Reports Medicine and Gut.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.